The algorithm composed of three immunohistochemical parameters selected on the basis of their prognostic and evolutionary importance represents a valuable auxiliary diagnostic tool in the detection of multiple and familial primary melanomas with CDKN2A homozygous deletion as a cost-effective measure of mutational status prediction. This evidence concerns the gene CDKN2A and melanoma.